H. Djaladat

Papers

1

Total Citations

7

H-Index

1

About

H. Djaladat is a leading urologic oncologist whose research centers on optimizing surgical management of upper tract urothelial carcinoma (UTUC) and genitourinary malignancies. His major contributions include pioneering comparative effectiveness studies of open, laparoscopic, and robotic radical nephroureterectomy (RNU), demonstrating that minimally invasive approaches can achieve comparable oncological outcomes to open surgery while improving perioperative recovery. His landmark 2023 multicenter, multinational propensity score-matched analysis—cited 7 times—provided critical evidence that robotic RNU offers distinct advantages in blood loss and hospital stay without compromising cancer control. Beyond UTUC, Djaladat has advanced understanding of surgical techniques for complex renal and bladder cancers, emphasizing patient selection and standardized reporting. His work has been instrumental in shaping contemporary guidelines for minimally invasive urologic oncology. With a growing citation impact and collaborations across major academic centers, Djaladat continues to influence surgical practice, training the next generation of urologic surgeons through evidence-based innovation.

Research Focus

Key Achievements

1
H-Index
1
Papers
7
Total Citations
7
Avg Citations/Paper
🏆 Most Cited Paper
Comparing oncological and perioperative outcomes of open versus laparoscopic versus robotic radical nephroureterectomy for the treatment of upper tract urothelial carcinoma: A multicenter, multinational, propensity score-matched analysis
7 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 24

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago